|

MADRE (Mammograms Available Due to Research and Education)

RECRUITINGN/ASponsored by University of Illinois at Chicago
Actively Recruiting
PhaseN/A
SponsorUniversity of Illinois at Chicago
Started2023-03-14
Est. completion2027-08-31
Eligibility
Age40 Years – 74 Years
SexFEMALE
Healthy vol.Accepted
Locations2 sites

Summary

The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat Breast Cancer (BC) screening.

Eligibility

Age: 40 Years – 74 YearsSex: FEMALEHealthy volunteers accepted
Aim 1

Inclusion Criteria:

* female biological sex
* identification as Latinas
* non-adherence to USPSTF guidelines (42-74 years old, no mammogram in past 2 years, no previous BC diagnosis)
* no previous history of health volunteerism
* not a network member enrolled in Aim 2.

Exclusion Criteria

\* Not meeting at least one of the aforementioned Aim 1 inclusion criteria.

Aim 2.

Inclusion Criteria:

* female biological sex
* eligibility to obtain BC screenings by USPSTF guidelines (i.e., 40-74 years old, no personal BC history)
* referral from Aim 1 participants
* no previous history of health volunteerism
* no participation in the RCT (not an Aim 1 participant, no Session #3 attendance).

Exclusion Criteria:

* Not meeting at least one of the aforementioned Aim 1 inclusion criteria.

Conditions3

Breast CancerBreast Cancer ScreeningCancer

Locations2 sites

Mile Square Health Center
Chicago, Illinois, 60612
Jocelyn Perez312-996-6337jocelynp@uic.edu
University of Illinois Health
Chicago, Illinois, 60612
Jocelyn Perez3129966337jocelynp@uic.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.